$EXAS Headlines

New Post Public Reply Private Reply Replies (0) Message Board

Oct 7, 2014 at 1:32 PM

$EXAS Headlines

Skullcandy gains on upgrade,Tesla reverses gains
2:37 p.m. Aug. 12, 2014
- Sue Chang

FDA approves DNA test for colon cancer
7:07 a.m. Aug. 12, 2014
- Joseph Walker

Puma Biotech’s blast-off is not a typical short squeeze
12:10 p.m. July 23, 2014
- Tomi Kilgore

6 stocks to watch
3:41 p.m. July 16, 2014
- The Trading Deck

Fourteen stocks for 2014 halftime report
11:49 a.m. July 8, 2014
- The Trading Deck

A very Exact opportunity in biotech
12:06 p.m. April 4, 2014
- The Trading Deck

Investors let air out of biotech amid overheating, pricing concerns

1:42 p.m. March 21, 2014
- Russ Britt

Mayo takes the rap for Exact's test leak, but stock gain remains a puzzle

4:48 p.m. March 19, 2014
- Russ Britt

Company's plan to release positive cancer screening results goes awry

12:24 p.m. March 19, 2014
- Russ Britt

Fourteen stocks for 2014
1:02 a.m. Jan. 7, 2014
- Kirk Spano

Biotech volatility can mean danger or opportunity
1:09 p.m. Oct. 23, 2013
- The Trading Deck

Three calls with big upside
1:14 p.m. Sept. 25, 2013
- The Trading Deck

Build your own hedge fund
1:39 p.m. Sept. 13, 2013
- The Trading Deck

Exact Sciences up 7.5% in premarket
8:13 a.m. Oct. 8, 2012
- Steve Gelsi

Stocks to watch Tuesday: Pfizer, Teleflex, Groupon
6:56 a.m. Aug. 14, 2012
- MarketWatch

An Exact opportunity
1:24 p.m. Aug. 9, 2012
- The Trading Deck

Hot stocks to watch
6:57 a.m. Aug. 8, 2012
- Dow Jones

Buy-and-hold is mostly right
1:59 p.m. June 29, 2012
- The Trading Deck

Trading vs. investing
12:02 a.m. June 5, 2012
- The Trading Deck

Small cap stocks and teenagers are a lot alike
7:34 a.m. March 2, 2012
- The Trading Deck

Exact Sciences - An Alpha Opportunity

5:14 p.m. Oct. 6, 2014
- Seeking Alpha

A Look At Exact Sciences Corporation's Stock

2:04 p.m. Oct. 1, 2014
- benzinga.com

ColoMarker cleared in Europe

9:41 a.m. Sept. 30, 2014
- Seeking Alpha

The Big Money's Favorite Biotech Stock

2:26 p.m. Sept. 29, 2014
- benzinga.com

'Mad Money' Lightning Round: Transocean Is a House of Pain

6:00 a.m. Sept. 23, 2014
- TheStreet.com

Cramer's Lightning Round - Don't Go Near Transocean (9/22/14)

5:45 a.m. Sept. 23, 2014
- Seeking Alpha

Jim Cramer's 'Mad Money' Recap: An Unsettling Market Decline

8:21 p.m. Sept. 22, 2014
- TheStreet.com

Biggest Movers in Healthcare Stocks Now – ANAC CLDX VRTX EXAS

7:45 a.m. Sept. 19, 2014
- InvestorPlace.com

SEC Slaps Biotech Hedge Fund for Short-Selling Violations

1:04 p.m. Sept. 16, 2014
- TheStreet.com

A Potential Game Changer In Cancer Screening

10:32 a.m. Sept. 16, 2014
- Seeking Alpha

Today's Post-Market Laggard Is Exact (EXAS)

7:33 p.m. Sept. 9, 2014
- TheStreet.com

Exact (EXAS) In A Perilous Reversal

9:52 a.m. Sept. 4, 2014
- TheStreet.com

Exact Sciences Corp. (EXAS) in Focus: Stock Rises 6.3% - Tale of the Tape

8:51 a.m. Sept. 4, 2014
- Zacks.com

Exact Sciences continues bull run

10:10 a.m. Sept. 3, 2014
- Seeking Alpha

Exact (EXAS) Strong On High Relative Volume Today

10:01 a.m. Sept. 3, 2014
- TheStreet.com

Hottest Healthcare Stocks Now – EXAS ACHN HALO CLDX

9:00 a.m. Sept. 3, 2014
- InvestorPlace.com

Biggest Movers in Healthcare Stocks Now – SPNC TRNX EXAS EXAM

1:15 p.m. Sept. 2, 2014
- InvestorPlace.com

Biggest Movers in Healthcare Stocks Now – MNKD RMD PRGO EXAS

8:30 a.m. Aug. 27, 2014
- InvestorPlace.com

Biggest Movers in Healthcare Stocks Now – ISIS THRX EXAS CBPO

6:00 a.m. Aug. 26, 2014
- InvestorPlace.com

Hottest Healthcare Stocks Now – PBYI ISIS EXAS IMGN

8:30 a.m. Aug. 25, 2014
- InvestorPlace.com

Watch List for Biotech Equities - Immunomedics, Aeterna Zentaris, OPKO Health, Navidea Biopharma, and Exact Sciences
8:50 a.m. Sept. 30, 2014
- PR Newswire - PRF

Exact Sciences Announces Group Health Cooperative as First Health
Plan in Wisconsin to Cover Cologuard®
8:45 a.m. Sept. 22, 2014
- BusinessWire - BZX

Exact Sciences to participate in Baird’s 2014 Health Care Conference
4:30 p.m. Aug. 28, 2014
- BusinessWire - BZX

Momentum Indicators for Biotech Stocks -- Exact Sciences, BioCryst Pharma, Spectrum Pharma, Aeterna Zentaris, and CTI BioPharma
8:50 a.m. Aug. 25, 2014
- PR Newswire - PRF

Exact Sciences Announces Mayo Clinic as First Healthcare System to
Offer Cologuard®
8:04 a.m. Aug. 25, 2014
- BusinessWire - BZX

Drug Approvals, Financial Results, Market Activity, New Mobile Applications, and Company Updates - Research Reports on Intercept, Exact Sciences, Thermo Fisher Scientific, Illumina and Agilent
9:00 a.m. Aug. 15, 2014
- PR Newswire - PRF

FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer Screening Test
7:00 a.m. Aug. 12, 2014
- PR Newswire - PRF

Exact Sciences to Participate in Canaccord Genuity Growth Conference
9:01 a.m. Aug. 7, 2014
- BusinessWire - BZX

Doyle, Arora elected; Sterling reelected to Exact Sciences’ board of
directors
4:31 p.m. July 24, 2014
- BusinessWire - BZX

Exact Sciences Reports Second-Quarter 2014 Financial Results
7:31 a.m. July 22, 2014
- BusinessWire - BZX

Biotech Stocks Scanner -- Regeneron Pharma, BioCryst Pharma, Spectrum Pharma, Exact Sciences, and Vical Inc.
9:10 a.m. July 21, 2014
- PR Newswire - PRF

Exact Sciences to host second-quarter 2014 results, annual meeting
webcasts and calls
9:45 a.m. July 16, 2014
- BusinessWire - BZX

Exact Sciences President, CEO and Chairman Kevin T. Conroy Named EY
Entrepreneur Of The Year™ 2014 Award winner for the Midwest
9:00 a.m. June 20, 2014
- BusinessWire - BZX

Biotech Stocks Technical Report -- Research on Exact Sciences, Anacor Pharma, Cubist Pharma, and Agenus
6:10 a.m. June 9, 2014
- PR Newswire - PRF

Exact Sciences to Participate in Goldman Sachs Global Healthcare
Conference
9:15 a.m. June 5, 2014
- BusinessWire - BZX

Exact Sciences to Participate in June Investor Conferences
10:01 a.m. May 28, 2014
- BusinessWire - BZX

Technical Data on Biotech Stocks -- Research on Exact Sciences, Amgen, Exelixis, and Incyte
9:57 a.m. May 6, 2014
- PR Newswire - PRF

Released and Scheduled Earnings Results - Analyst Notes on Pacira, Exact Sciences, Synageva, Agios and Vanda Pharmaceuticals
8:00 a.m. May 6, 2014
- PR Newswire - PRF

Molecular Diagnostics Markets
7:51 p.m. May 5, 2014
- PR Newswire - PRF

The World Market for Cancer Diagnostics, 5th Edition: Precision and Personalized Testing Arrives
7:37 p.m. May 5, 2014
- PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aurra Markets Wins 'Most Transparent Broker' Award 2026

Spotlight on Transparency in Trading Alright, so Aurra Markets snagged the 'Most Transparent Broker' award at the Money Expo in Mumbai this year. From the greasy streets of trading floors to the polished halls of Jio World Convention Centre, transparency is one of those golden words you hear tossed around, but like finding a needle in a haystack, it’s not always easy to...

LITEON Bets Big on Liquid Cooling with DCX Stake

Liquid Cooling: The AI Data Center Game Changer Alright, here's a twist in the tech saga that even a crusty old trader like me finds intriguing. LITEON (2301.TW) has made a bold move investing in DCX Liquid Cooling Systems with a $176 million deal for 25% equity. We're talking about liquid cooling here—it's the magic ingredient when your AI and HPC data centers start...

Ares Management Heads to Barclays Conference Spotlight

All Eyes on Ares – From the Trading Floor to Barclays Nothing like the crisp snap of traders' attention when big players like Ares Management Corporation (NYSE:ARES) are set to spill some beans at a fancy conference. Come September 16, 2026, Ares' head honcho, Michael Arougheti, will be hitting the stage at the Barclays Global Financial Services Conference. It’s the...

Curaleaf Eyes Growth: Conference Signals Opportunities

Curaleaf's Strategic Move: Getting in Front of Investors Here comes Curaleaf Holdings, stepping into the spotlight with their eye on increasing investor engagement. Announcing their participation in the ATB Cormark Capital Markets 2026 Fall Institutional Investor Conference, the folks at Curaleaf aren't just talking—they're putting their top brass under the lights. You...

Navimow's H5 Pro Mower Marries Tech with Nature Care

Garden Tech Reinvented: Enter the H5 Pro Mower Welcome to the 21st-century garden, where robotic ingenuity meets a genuine regard for nature. Folks, the Navimow H5 Pro just rolled onto the scene and it’s tearing up the old playbook of garden maintenance. It’s like blending Silicon Valley tech with Jane Goodall’s wildlife sensibilities. We're talking zero-edge...

Joseph Spine Opens New Regenerative Therapy Center

Regenerative Medicine: A New Frontier in Spine Care When spine care gets a facelift, you take notice. Joseph Spine Institute, a heavyweight in the spine care game, just threw hat into the regenerative ring. We're talking about using a patient's own cells to mend what's broken—that's advanced. They're launching a Regenerative Therapy Center in Tampa, ready to offer these...

Eosera Defies Odds with Texas-Made Ear Care Dominance

Who would've thought an ear care outfit outta Fort Worth could snag a spot on the Inc. 5000 list for six years running? That's right, eosera® is hanging tough, even while the industry's been in a tailspin and tariffs have been squeezing everyone’s margins. Pushing Through Tough Terrain The ear care sector isn't exactly the first place investors look for a splash,...

Perspecta's Study Reveals Troubling Data Accuracy Gaps

Data Accuracy in Healthcare: A Persistent Problem Just when you think data's about numbers and cold, hard facts, healthcare jolts you awake. Perspecta's fresh insights onto provider data accuracy aren't just a snooze fest of statistics but a genuine wake-up call. This report peels open a can of worms some might prefer to ignore. With only half of provider data accurate,...

Nasdaq Flashes Warning Signs for Scage Future's Compliance

Two Strikes from Nasdaq: A Wake-Up Call? Scage Future's getting a double-shot of reality from Nasdaq after slipping under crucial thresholds. Here's the score: Scage's been dinged on their Market Value of Listed Securities (MVLS) and Market Value of Publicly Held Shares (MVPHS). Over a stretch from mid-July to late August, these benchmarks floundered below the line. The...

Alcatraz AI: A Silent Titan in Data Center Security

Why Alcatraz AI is the Security of Choice Forget flashy press releases and splashy marketing campaigns. Alcatraz AI, a company operating out of the hustle and bustle of Cupertino, has managed to quietly dominate a key sector without many folks being the wiser. What's their claim to fame, you ask? They're the chosen gatekeepers for over half of the hyperscale data centers...